GET THE LATEST UPDATES
Receive the latest event information about key speakers, sponsorship opportunities and exhibiting.
November 9-11, 2020 | Virtual Conference
Sarah Ikenberry is a Senior Communication Advisor at the Office of Therapeutic Biologics and Biosimilars (OTBB) in the Food and Drug Administration’s (FDA) Center for Evaluation and Research (CDER). She provides communication advice and support to senior leaders and the agency about communicating strategic priorities, initiatives, and educational information about biosimilar and interchangeable products. Sarah previously worked in CDER’s Office of Communications where she planned and implemented strategic communication strategies and marketing activities about high-priority, complex CDER policy matters and public health and regulatory issues related to drug products. While there, she also helped develop and launch FDA’s first campaign about biosimilar and interchangeable products. Sarah has a Master of Arts in Communication from Johns Hopkins University.